Unbound MEDLINE

Use of progesterone to prevent preterm birth at a tertiary care center. The Journal of reproductive medicine [J Reprod Med] Journal article

 
TitleUse of progesterone to prevent preterm birth at a tertiary care center.
Author(s)Bailit JL, Berkowitz R, Thorp JM, Cleary K, Hartmann KE, Mercer BM 
InstitutionDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio 44109, USA. jbailit@metrohealth.org
SourceJ Reprod Med 2007 Apr; 52(4):280-4.
AbstractOBJECTIVE: To assess the prescription patterns of progesterone for the prevention of preterm birth in a tertiary center.
STUDY DESIGN: We examined electronic medical records for all women receiving care in the high risk obstetric clinics at a tertiary care center from July 2003 to June 2004. Demographic information, progesterone offers, progesterone therapy accepted and received, and barriers to receiving progesterone were collected. Women were placed into 1 of 4 categories: appropriate offer, appropriate nonoffer, inappropriate offer and inappropriate nonoffer.
RESULTS: Five hundred two patients sought prenatal care in the clinics during the study period. Of 143 women with a prior preterm birth, 60 (42%) were considered to be candidates for progesterone. Of these, 34 of 60 (57%) were offered progesterone therapy (appropriate offer). Of the 442 women who were not appropriate progesterone candidates, 9 (2%) were offered progesterone (inappropriate offer).
CONCLUSION: Our data suggest that a substantial proportion of eligible women are not being offered progesterone for the prevention of preterm birth. More data are needed regarding barriers to progesterone use and what programs may best influence physicians to use progesterone appropriately.
Languageeng
Pub Type(s)Journal Article
Research Support, N.I.H., Extramural
PubMed ID17506366
  
Advertise on this site.